A catalytically silent FAAH-1 variant drives anandamide transport in neuronsJin Fu, Daniele Piomelli, Andrea Armirotti et al.|Nature Neuroscience|2011Cited by 170
Multitarget Drug Discovery for Alzheimer's Disease: Triazinones as BACE‐1 and GSK‐3β InhibitorsFederica Prati, Andrea Cavalli, Angela De Simone et al.|Angewandte Chemie International Edition|2014Cited by 123
Versatility of the Curcumin Scaffold: Discovery of Potent and Balanced Dual BACE-1 and GSK-3β InhibitorsRita Maria Concetta Di Martino, Federica Belluti, Angela De Simone et al.|Journal of Medicinal Chemistry|2015Cited by 123
3,4-Dihydro-1,3,5-triazin-2(1<i>H</i>)-ones as the First Dual BACE-1/GSK-3β Fragment Hits against Alzheimer’s DiseaseFederica Prati, María Laura Bolognesi, Angela De Simone et al.|ACS Chemical Neuroscience|2015Cited by 67
A Triazolotriazine‐Based Dual GSK‐3β/CK‐1δ Ligand as a Potential Neuroprotective Agent Presenting Two Different Mechanisms of Enzymatic InhibitionStephanie Federico, Irene Marcovich, Teresa De Vita et al.|ChemMedChem|2018Cited by 39